Our aim was to investigate if genetic variations in the visfatin gene could be associated with obesity, glucose tolerance (Diabetes Mellitus Type 2) and cardiovascular (CV)risk–related alterations on a large sample of a population–based study in Spain. The gene discussed is NAMPT; the disease is diabetes mellitus.